Titan Pharmaceuticals (OTCMKTS:TTNP) President Sunil Bhonsle purchased 50,000 shares of the business’s stock in a transaction on Tuesday, August 25th. The shares were purchased at an average price of $0.70 … · 1 day ago
Titan Pharmaceuticals (OTCMKTS:TTNP) opened at 0.72 on Friday. The company has a 50 day moving average of $0.76 and a 200-day moving average of $0.70. Titan Pharmaceuticals has a 12-month low of $0.44 and a 12-month high of $0.99. The …
Ticker Report · 8/14/2015
Titan Pharmaceuticals (OTCMKTS:TTNP)‘s stock had its “buy” rating reissued by Roth Capital in a research note issued on Saturday, Analyst Ratings.Net reports. Shares of Titan Pharmaceuticals (OTCMKTS:TTNP) opened at 0.8298 on Friday. Titan ... · 7/19/2015
More from Bing News
This low priced profitable pain management company is coiled up again. News should be coming out with an FDA approval as the final... if you surmise what this company can do 1-3 months out or less . There`s always some cash rich companies looking …
Stockhouse · 8/14/2015
Titan Pharmaceuticals (OTCMKTS:TTNP)‘s stock had its “buy” rating reiterated by equities research analysts at Roth Capital in a research note issued to investors on Friday. They currently have a $1.25 price target on the specialty pharmaceutical ...
Mideast Times · 6/13/2015
Watch the video to learn about the probability of TITAN PHARMACEUTICALS INC (TTNP) Chart Signal as of Aug 16, 2015 This free program will calculate the probabilities of TITAN PHARMACEUTICALS INC (TTNP) stock chart
Hot Stocked · 8/16/2015
In another filing, Kevin Kotler‘s Broadfin Capital disclosed adding Titan Pharmaceuticals, Inc. (OTCBB:TTNP) to its equity portfolio. The fund reported holding over 6.37 million shares of the company, the stake being equal to 5.8% of the common stock.
INSIDER MONKEY · 10/13/2014
Shares of pink sheet stock Titan Pharmaceuticals Inc. (OTC: TTNP) could be one to watch related to the 900% upside swing in Vanda Pharmaceuticals (Nasdaq: VNDA) after the FDA approved iloperidone for the acute treatment of adult patients with …
StreetInsider · 5/7/2009 Globalstar Inc. GSAT, -2.82% shares closed up a modest 3.03 percent on Wednesday on around 6.2 million shares traded. The stock has closed in the green two trading days in a row. On Wednesday the …
Market Watch · 11/14/2013
On September 14, 2012, Titan Pharmaceuticals (OTCQB:TTNP) announced it had entered into a stock purchase and option agreement with another pharmaceutical company for the potential license of Probuphine. As part of the transaction, Titan sold 3.4 …
Seeking Alpha · ByJason Napodano · 9/14/2012